Evidence map›Paper›PMID 29382719›Full record

ArticleThe Journal of biological chemistry2018

Tyrosine phosphorylation switching of a G protein.

Bo Li, Meral Tunc-Ozdemir, Daisuke Urano, Haiyan Jia, Emily G Werth, David D Mowrey, Leslie M Hicks, Nikolay V Dokholyan, Matthew P Torres, Alan M Jones

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Heterotrimeric G Proteins in Plants: Canonical and Atypical Gα Subunits.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Bo LiDepartments of Biology, Chapel Hill, North Carolina 27599.
Meral Tunc-OzdemirDepartments of Biology, Chapel Hill, North Carolina 27599.
Daisuke UranoDepartments of Biology, Chapel Hill, North Carolina 27599; Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 117604, Singapore.
Haiyan JiaDepartments of Biology, Chapel Hill, North Carolina 27599.
Emily G WerthDepartment of Chemistry, Chapel Hill, North Carolina 27599.
David D MowreyBiochemistry/Biophysics, Chapel Hill, North Carolina 27599.
Leslie M HicksDepartment of Chemistry, Chapel Hill, North Carolina 27599.
Nikolay V DokholyanBiochemistry/Biophysics, Chapel Hill, North Carolina 27599.
Matthew P TorresDepartment of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30332.
Alan M JonesDepartments of Biology, Chapel Hill, North Carolina 27599; Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599. Electronic address: alan_jones@unc.edu.
Georgia Institute of Technology · USTemasek Life Sciences Laboratory · SGUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Novel Mechanisms Regulating the Heterotrimeric G Protein ComplexR01GM065989 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JONES, ALAN M. · 2002 to 2023
$5.5M
Retroviral Genomic RNA Dimer Structure and FunctionR01GM064803 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEEKS, KEVIN M · 2002 to 2016
$3.7M
Protein Misfolding and AggregationR01GM080742 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOKHOLYAN, NIKOLAY · 2007 to 2015
$2.8M
Engineering allostery for in vivo protein controlR01GM123247 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOKHOLYAN, NIKOLAY · 2017 to 2019
$1.5M
G gamma N-terminal tails as regulators of G protein signalingR01GM117400 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI TORRES, MATT PHILLIP · 2016 to 2019
$1.2M
Integrating cheminformatics and molecular simulations for virtual drug screeningR01GM114015 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOKHOLYAN, NIKOLAY · 2016 to 2019
$1.1M
NCI NIH HHS P30 CA016086NIGMS NIH HHS R01 GM064803NIGMS NIH HHS R01 GM065989NIGMS NIH HHS R01 GM080742NIGMS NIH HHS R01 GM114015NIGMS NIH HHS R01 GM117400NIGMS NIH HHS R01 GM123247
6 · The paper itself

Abstract

Heterotrimeric G protein complexes are molecular switches relaying extracellular signals sensed by G protein-coupled receptors (GPCRs) to downstream targets in the cytoplasm, which effect cellular responses. In the plant heterotrimeric GTPase cycle, GTP hydrolysis, rather than nucleotide exchange, is the rate-limiting reaction and is accelerated by a receptor-like regulator of G signaling (RGS) protein. We hypothesized that posttranslational modification of the Gα subunit in the G protein complex regulates the RGS-dependent GTPase cycle. Our structural analyses identified an invariant phosphorylated tyrosine residue (Tyr

Indexed as

Protein Processing, Post-TranslationalAmino Acid SubstitutionArabidopsisArabidopsis ProteinsGTP-Binding Protein alpha SubunitsMutation, MissensePhosphorylationRGS ProteinsTyrosineArabidopsis ProteinsGPA1 protein, ArabidopsisGTP-Binding Protein alpha SubunitsRGS1 protein, ArabidopsisRGS ProteinsTyrosineG protein-coupled receptor (GPCR)GTPaseGTPase-activating protein (GAP)GTP hydrolysisguanine-nucleotide exchange factorheterotrimeric G proteinphosphotyrosine signalingprotein phosphorylationregulator of G protein signaling (RGS)substrate phosphoswitching

Identifiers

PMID29382719
PMCPMC5880138
OpenAlexW2786862020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.